The outbreak of the novel coronavirus (COVID-19) has created business disruptions worldwide, with ripple effects across markets and industries. Executives are receiving many challenging demands to interpret these uncertain times and make decisions for their business. However, in the middle of this highly unusual crisis that is unlikely to be resolved soon, assumptions, forecasts, and expectations from today become quickly obsolete.
Pharma CI, in partnership with DuckerFrontier, held a virtual event in lieu of the live conference in Zurich, which has been moved to November 5-6. You can learn more and register for the rescheduled live conference here.
In this 90-minute presentation, our panel of healthcare executives and experts shared the adaptations healthcare companies are making in the face of the coronavirus pandemic, and steps to mitigate business risk. Presentation topics included:
For all of our latest updates and impacts for global business, visit our COVID-19 Resource Hub, a centralized location with all of the latest insights from our expert analysts that your business needs to navigate continued uncertainty surrounding COVID-19.
About Pharma CI
The Pharma CI Conference & Exhibition is THE INDUSTRY’S GOLD STANDARD for senior level pharma, biotech, and device professionals seeking the latest news and the rare chance to network with all the industry’s luminaries. Click here to learn more.